Astrocyte begins Phase 1 study re brain injury
Astrocyte Pharmaceuticals has begun its first-in-human Phase 1 clinical study with the dosing of a first subject with AST-004, a promising investigational therapeutic being advanced as a...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Astrocyte Pharmaceuticals has begun its first-in-human Phase 1 clinical study with the dosing of a first subject with AST-004, a promising investigational therapeutic being advanced as a...
View this email in your browser Weekly Roundup – June 16, 2022 We are at the BIO International Convention! Thank you to our sponsors and all...
Formed from the Governor’s Workforce Council and working in collaboration with the Greater New Haven Chamber of Commerce, SPRINT (Student Program to Ready Interns for Next-generation Talent)...
In an op-ed, Paul Pescatello, chairman of We Work for Health Connecticut, writes: Lately, stakeholders in the health economy have been playing the “blame game” over...
Arvinas is calling for entries for their inaugural Early Career Research Award, which will recognize the efforts of up-and-coming researchers bringing innovation, new approaches and creative...
Accelerator for Biosciences in Connecticut, ABCT, is a competitive entry, 6-month long program designed for entrepreneurial research students and faculty, MBAs and MDs interested in forming new...
View this email in your browser Weekly Roundup – June 9, 2022 For the...
Between 5-8% of the human genome consists of sequences with viral origin, namely endogenous retroviruses. Their RNA expression has been correlated with several diseases, including...
The National Accreditation Program for Breast Centers has granted accredited status to the UConn Health Carole and Ray Neag Comprehensive Cancer Center. To achieve voluntary NAPBC accreditation,...
View this email in your browser Career News – June 7, 2022 Our new Career Portal is now active! We are thrilled to announce the...